Early cannabis use and Schizotypal Personality Disorder Symptoms from adolescence to middle adulthood

Schizophrenia Research

Volumn 137, Issue 1-3, 2012, Pages 45-49

  Anglin, Deidre M ^a   Corcoran, Cheryl M ^b   Brown, Alan S ^b   Chen, Henian ^c   Lighty, Quenesha ^a   Brook, Judith S ^d   Cohen, Patricia R ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b Department of Psychiatry ^*  (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Early cannabis use; Longitudinal; Schizotypal personality

Indexed keywords

ADOLESCENCE; ADOLESCENT; ADULT; ADULTHOOD; ANXIETY DISORDER; ARTICLE; CANNABIS ADDICTION; CHILD; CIGARETTE SMOKING; COHORT ANALYSIS; COMMUNITY SAMPLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; ONSET AGE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SCHOOL CHILD; SYMPTOM; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MARIJUANA ABUSE; MODELS, STATISTICAL; NEW YORK; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 84862829106     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.01.019     Document Type: Article

References (41)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (third edn) (DSM-III) 1980, American Psychiatric Association, Washington, D. C.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2001, American Psychiatric Association, Washington, D. C, (DSM-IV-TR). Fourth Edn Revised.
3. Andreasson S., Allebeck P., Engstrom A., Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987, 2:1483-1486.
4. Anglin D.M., Cohen P.R., Chen H. Duration of early maternal separation and prediction of schizotypal symptoms from early adolescence to midlife. Schizophr. Res. 2008, 103:143-150.
5. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T.E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002, 325:1212-1213.
6. Arseneault L., Cannon M., Witton J., Murray R.M. Causal association between cannabis and psychosis: examination of the evidence. Br. J. Psychiatry 2004, 184:110-117.
7. Barkus E., Lewis S. Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample. Psychol. Med. 2008, 38:1267-1276.
8. Bernstein D.P., Cohen P., Velez C.N., Schwab-Stone M., Siever L.J., Shinsato L. The prevalence and stability of the DSM-III-R personality disorders in a community-based survey of adolescents. Am. J. Psychiatry 1993, 150:1237-1243.
9. Brook J.S., Cohen P., Brook D.W. Longitudinal study of co-occurring psychiatric disorders and substance use. J. Am. Acad. Child Adolesc. Psychiatry 1998, 37:322-330.
10. Cohen P., Cohen J. Life Values and Adolescent Mental Health 1996, Lawrence Erlbaum Associates, Mahwah, NJ.
11. Cohen P., Chen H., Crawford T.N., Brook J.S., Gordon K. Personality disorders in early adolescence and the development of later substance use disorders in the general population. Drug Alcohol Depend. 2007, 88:S71-S84.
12. Cohen A.S., Buckner J.D., Najolia G.M., Steward D.W. Cannabis and psychometrically-defined schizotypy: use, problems and treatment considerations. J. Psychiatr. Res. 2011, 45:548-554.
13. Compton M.T., Goulding S.M., Walker E.F. Cannabis use, first-episode psychosis, and schizotypy: a summary and synthesis of recent literature. Curr. Psychiatry Rev. 2007, 3:161-171.
14. Corcoran C.M., Kimhy D., Stanford A., Khan S., Walsh J., Thompson J., Schobel S., Harkavy-Friedman J., Goetz R., Colibazzi T., Cressman V., Malaspina D. Temporal association of cannabis use with the symptoms in individuals at clinical high risk for psychosis. Schizophr. Res. 2008, 106:286-293.
15. Costello E.J., Edelbrock C.S., Duncan M.K., Kalas R. Testing of the NIMH Diagnostic Interview Schedule for Children (DISC) in a Clinical Population: Final Report to the Center for Epidemiological Studies, NIMH 1984, University of Pittsburgh, Pittsburg, PA.
16. Crawford T.N., Cohen P., Johnson J.G., Kasen S., First M.B., Gordon K., Brook J.S. Self-reported personality disorder in the children in the community sample: convergent and prospective validity in late adolescence and adulthood. J. Pers. Disord. 2005, 19:30-52.
17. D'Souza D.C., Abi-Saab W.M., Madonick S., Forselius-Bielen K., Doersch A., Braley G., Gueorguieva R., Cooper T.B., Krystal J.H. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol. Psychiatry 2005, 57:594-608.
18. Esterberg M.L., Goulding S.M., McClure-Tone E.B., Compton M.T. Schizotypy and nicotine, alcohol, and cannabis use in a non-psychiatric sample. Addict. Behav. 2009, 34:374-379.
19. Fergusson D.M., Poulton R., Smith P.F., Boden J.M. Cannabis and psychosis. Br. J. Psychiatry 2006, 332:172-175.
20. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. The structured clinical interview for DSM-III-R personality disorders (SCID-II), Part I: description. J. Personal. Disord. 1995, 9:83-91.
21. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-Patient Edition. (SCID-I/NP) 1996, New York State Psychiatric Institute, New York, NY.
22. Fridberg D., Vollmer J., O'Donnell B., Skosnik P. Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Res. 2011, 186:46-52.
23. Genetic Risk and Outcome of Psychosis (GROUP) Investigators Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Arch. Gen. Psychiatry 2011, 68:138-147.
24. Hyler S.E., Skodol A.E., Kellman H.D., Oldham J.M., Rosnick L. Validity of the Personality Diagnostic Questionnaire-revised: comparison with two structured interviews. Am. J. Psychiatry 1990, 147:1043-1048.
25. Johnson J.G., Cohen P., Kasen S., Skodol A., Brook J. Age-related change in personality disorder trait levels between early adolescence and adulthood: a community-based longitudinal investigation. Acta Psychiatr. Scand. 2000, 102:265-275.
26. Kasen S., Cohen P., Skodol A., First M., Johnson J., Brook J.S., Oldham J. Comorbid personality disorder and treatment use in a community sample of youths: a 20-year follow-up. Acta Psychiatr. Scand. 2007, 115:56-65.
27. Kuepper R., van Os J., Lieb R., Wittchen H., Höfler M., Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10year follow-up cohort study. BMJ 2011, 342:d738.
28. Large M., Sharma S., Compton M.T., Slade T., Nielssen O. Cannabis use and early onset psychosis: a systematic meta-analysis. Arch. Gen. Psychiatry 2011, 68:555-561.
29. Lenzenweger M.F. Stability and change in personality disorder features. Arch. Gen. Psychiatry 1999, 56:1009-1015.
30. Macleod J., Oakes R., Copello A., Crome I., Egger M., Hickman M., Oppenkowski R., Stokes-Lampard H., Smith G.D. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004, 363:1579-1588.
31. Moore T.H.M., Zammit S., Lingford-Hughes A., Barnes T.R.E., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
32. Murray R.M., Morrison P.D., Henquet C., DiForti M. Cannabis, the mind and society: the hash realities. Nat. Rev. Neurosci. 2007, 8:885-895.
33. Rössler W., Vetter S., Müller M., Gallo W., Haker H., Kawohl W., Lupi G., Ajdacic-Gross V. Risk factors at the low end of the psychosis continuum: much the same as at the upper end?. Psychiatry Res. 2011, 189:77-81.
34. Schiffman J., Nakamura B., Earleywine M., LaBrie J. Symptoms of schizotypy precede cannabis use. Psychiatry Res. 2004, 134:37-42.
35. Skodol A.E., Oldham J.M., Rosnick L., Kellman H.D., Hyler S.E. Diagnosis of DSM-III-R personality disorders: a comparison of two structured interviews. Int. J. Methods Psychiatr. Res. 1991, 1:13-26.
36. Skodol A., Johnson J., Cohen P., Sneed J., Crawford T. Personality disorder and impaired functioning from adolescence to adulthood. Br. J. Psychiatry 2007, 190:415-420.
37. Skosnik P.D., Spatz-Glenn L., Park S. Cannabis use is associated with schizotypy and attentional disinhibition. Schizophr. Res. 2001, 48:83-92.
38. Spitzer R.L., Williams J.B.W. Structured Clinical Interview for DSM-IIIR Personality Disorders 1986, New York State Psychiatric Institute, New York, NY.
39. Verdoux H., Gindre C., Sorbara F., Tournier M., Swendsen J.D. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychol. Med. 2003, 33:23-32.
40. Williams J.H., Wellman N.A., Rawlins J.N. Cannabis use correlates with schizotypy in healthy people. Addiction 1996, 91:869-877.
41. Zammit S., Allebeck P., Andreasson S., Lundberg I., Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002, 325:1199.